Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity

Antiviral Res. 1996 Jan;29(1):91-3. doi: 10.1016/0166-3542(95)00926-4.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Antiviral Agents / therapeutic use*
  • CD4 Lymphocyte Count
  • Double-Blind Method
  • Drug Resistance, Microbial
  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / therapeutic use*
  • Humans
  • Isoquinolines / adverse effects
  • Isoquinolines / therapeutic use*
  • Quinolines / adverse effects
  • Quinolines / therapeutic use*
  • RNA, Viral / blood
  • Saquinavir
  • Zidovudine / adverse effects
  • Zidovudine / therapeutic use*

Substances

  • Antiviral Agents
  • HIV Protease Inhibitors
  • Isoquinolines
  • Quinolines
  • RNA, Viral
  • Zidovudine
  • Saquinavir